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Abstract
Background:  High-rate pacing is a valid stress test to be used in conjunction with
echocardiography; it is independent of physical exercise and does not require drug administration.
There are two main applications of pacing stress in the echo lab: the noninvasive detection of
coronary artery disease through induction of a regional transient dysfunction; and the assessment
of contractile reserve through peak systolic pressure/ end-systolic volume relationship at increasing
heart rates to assess global left ventricular contractility.
Methods: The pathophysiologic rationale of pacing stress for noninvasive detection of coronary
artery disease is obvious, with the stress determined by a controlled increase in heart rate, which
is a major determinant of myocardial oxygen demand, and thereby tachycardia may exceed a fixed
coronary flow reserve in the presence of hemodynamically significant coronary artery disease. The
use of pacing stress echo to assess left ventricular contractile reserve is less established, but
promising. Positive inotropic interventions are mirrored by smaller end-systolic volumes and higher
end-systolic pressures. An increased heart rate progressively increases the force of ventricular
contraction (Bowditch treppe or staircase phenomenon). To build the force-frequency
relationship, the force is determined at different heart rate steps as the ratio of the systolic
pressure (cuff sphygmomanometer)/end-systolic volume index (biplane Simpson rule). The heart
rate is determined from ECG.
Conclusion: Two-dimensional echocardiography during pacing is a useful tool in the detection of
coronary artery disease. Because of its safety and ease of repeatability noninvasive pacing stress
echo can be the first-line stress test in patients with permanent pacemaker.
The force-frequency can be defined as up- sloping (normal) when the peak stress pacing systolic 
pressure/end-systolic volume index is higher than baseline and intermediate stress values, biphasic 
with an initial up- sloping followed by a later down-sloping trend, or flat or negative when peak stress 
pacing systolic pressure/end-systolic volume index is equal or lower than baseline stress values. 
This approach is certainly highly feasible and allows a conceptually immaculate definition of 
contractility with prognostic usefulness, but its therapeutic implications remains to be established. 
Bowditch treppe, assessed with pacing stress, can be used to assess the optimal stimulation 
frequency and to optimise the patient's chronotropic response in programming rate-adaptive 
pacemakers.
Published: 09 December 2005
Cardiovascular Ultrasound 2005, 3:36 doi:10.1186/1476-7120-3-36
Received: 14 November 2005
Accepted: 09 December 2005
This article is available from: http://www.cardiovascularultrasound.com/content/3/1/36
© 2005 Gligorova and Agrusta; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
Page 2 of 11
(page number not for citation purposes)
Background
High-rate pacing is a valid stress test to be used in conjunc-
tion with echocardiography; it is independent of physical
exercise and does not require drug administration[1]. Its
evolution in the last 20 years started from an invasive
(intravenous) right atrial pacing modality, combined with
a ionising imaging technique such as radionuclide ven-
triculography; it moved to a seminvasive modality com-
bined with 2D echo, using transnasal[2] or transoral
catheter for transesophageal [3-8] left atrial pacing; and
finally evolved to a totally noninvasive modality with
external programming in patients with permanent pace-
maker for right atrial or ventricular pacing [1,9-11].
There are two main applications of pacing stress in the
echo lab: the noninvasive detection of coronary artery dis-
ease through induction of a regional transient dysfunc-
tion[1,11]; and the assessment of contractile reserve
through peak systolic pressure/ end-systolic volume rela-
tionship at increasing heart rates to assess global left ven-
tricular contractility[9,12].
Pathophysiological mechanisms of pacing
Pacing can be atrial or ventricular. The paced chamber is
the left atrium in transesophageal pacing and the right
atrium or the right ventricle in permanent pacemaker
stimulation[1].
The pathophysiologic rationale of pacing stress for nonin-
vasive detection of coronary artery disease is obvious, with
the stress determined by a controlled increase in heart
rate, which is a major determinant of myocardial oxygen
demand, and thereby tachycardia may exceed a fixed cor-
onary flow reserve in the presence of hemodynamically
significant coronary artery disease (fig. 1). With a control-
led increase in heart rate during pacing both cardiac vol-
umes and dimensions decreases and blood pressure does
not change significantly[1,9].
The drop in subendocardial -to- subepicardial flow
ratio[13] associated with rapid atrial pacing in the pres-
ence of a tight coronary stenosis, is critical to the develop-
ment of regional dysfunction, for regional percent systolic
thickening is linearly and tightly related to subendocar-
dial, but not to transmural flow[1].
In patients with permanent right ventricular pacing, per-
fusion defects can often be found in the inferior and api-
cal wall, which are probably the earliest activated sites
under right ventricular apical pacing. The regional coro-
nary flow reserve can be impaired in the dominant coro-
nary artery perfusing these regions, whereas it is usually
normal in the left anterior descending coronary artery[1].
This abnormality is at least partially responsible for the
uncertain specificity of stress myocardial scintigraphy
[14].
In patients with permanent pacemakers, chronic right
ventricular pacing as a cause of asynchronous electric acti-
vation of the left ventricle decreases mechanical load in
early versus late activated regions of the ventricular wall.
This mechanism induces asymmetric thickness of the left
ventricular wall and redistribution of left ventricular mass,
with thinning of early versus late activated myocar-
dium[1].
Septal motion during right ventricular pacing
Variations can be found according to the site of stimula-
tion, the pacing mode and the heart rate[1].
Septal wall motion- extraischemic determinants Figure 2
Septal wall motion- extraischemic determinants.
The pathways of ischemia – The pathophysiologic rationale  of pacing stress for noninvasive detection of coronary artery  disease is obvious with the stress determined by a controlled  increase in heart rate, which is a major determinant of myo- cardial oxygen demand, and thereby tachycardia may exceed  a fixed coronary flow reserve in the presence of hemody- namically significant coronary artery disease Figure 1
The pathways of ischemia – The pathophysiologic rationale 
of pacing stress for noninvasive detection of coronary artery 
disease is obvious with the stress determined by a controlled 
increase in heart rate, which is a major determinant of myo-
cardial oxygen demand, and thereby tachycardia may exceed 
a fixed coronary flow reserve in the presence of hemody-
namically significant coronary artery disease.
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A pre-ejection septal beaking is observed – similarly to
what can be found in other patients with relatively
delayed left ventricular activation, caused by left bundle
branch block or type B Wolff-Parkinson-White syn-
drome[15] (fig. 2). The pre-ejection period septal beaking
is not due to early activation and unopposed contraction
of the interventricular septum, but it rather occurs in
response to an altered transseptal pressure gradient. When
pacing causes the right ventricle to be activated before the
left, right ventricular pressure begins to increase in systole
before left ventricular pressure, altering the normal left-to-
right transseptal pressure gradient. Coincident with the
early unopposed increase in right ventricular pressure, the
septum abruptly moves posteriorly towards the left ventri-
cle. With the subsequent onset of left ventricular contrac-
tion, left ventricular pressure increases, the normal
transseptal pressure gradient is restored, and the septum
returns in the anterior direction towards its end-diastolic
position.
In the ejection phase, a ventricularly paced left ventricle
can show a normal posterior motion and thickening
(more frequent with pacing from right ventricular apex)
or a flat or paradoxical (anterior) motion (more frequent
with pacing from right ventricular outflow or right ven-
tricular inflow). The interpretation can be easier in the
first case than in the second case, especially considering
that in 30% of patients a normal or flat motion can
become paradox at high pacing rates over 120/min.
The interpretation must consider that regional wall
motion in the septum is differently affected by the pacing
mode(fig. 3). In the atrial stimulation mode, the normal,
physiological electrical activation sequence is preserved,
and therefore the septal wall motion is normal and there
are no special interpretation problems. About two out of
three patients with permanent pacemakers are studied in
the ventricular pacing mode. In about 30 % of right ven-
tricular-paced patients, the septal wall motion is normal,
but in the majority of them an anterior systolic interven-
tricular septal motion (paradoxal motion) is present at
baseline. In this case the reader must focus on wall thick-
ening rather than endocardial excursion, and on non-sep-
tal regions of the left anterior descending territory to
Different types of baseline septal motion and stress-induced ischemia according to the pacing- mode (AAI vs. VVI) and (in VVI)  according to the site of stimulation Figure 3
Different types of baseline septal motion and stress-induced ischemia according to the pacing- mode (AAI vs. VVI) and (in VVI) 
according to the site of stimulation. RV = right ventricle; IVS = interventricular septum.
AAI VVI, RV apex  VVI, RV IVS
IVS
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identify left anterior descending stenosis, but this inter-
pretation will always be a challenge, especially at high
heart rates [1].
Techniques of pacing stress echocardiography
Intravenous atrial pacing
With intravenous right atrial pacing, diagnostic results are
excellent. The technique is, however, invasive since cathe-
terization is required, which nullifies its utilization in the
echo lab[1].
Transesophageal atrial pacing
The technical possibility of doing transesophageal left
atrial pacing[3-8] was suggested more than 30 years ago
exclusively for the diagnosis and treatment of arrhyth-
mias. In subsequent years its utilization has been limited
by lack of consistent atrial capture and by patient discom-
fort resulting from high current requirement. Utilization
of the transesophageal approach as a stress test for
ischemia has become possible thanks to recent improve-
ments in this technique, enabling effective atrial capture
at a relatively low threshold, which reduced patient dis-
comfort, and transoral stimulation with 10 French cathe-
ters. The transesophageal approach sometimes is
ineffective: approximately two patients out of ten have to
be excluded either because of pacing-induced chest dis-
comfort not tolerated by the patient, unstable atrial cap-
ture, or early appearance of Luciani-Wenckebach second-
degree block. To avoid an atrioventricular block during
the stress test that will prevent reaching the maximum
heart rate, cycle length is progressively decreased to 400
ms prior to performing the continuous pacing of the tests
in order to select patients who require atropine sulfate
(0.02 mg/kg i.v.) premedication because of a low Wenck-
ebach point[1].
Noninvasive atrial pacing in patients with permanent pacemaker
The presence of a permanent pacemaker can be exploited
to perform a pacing stress in a totally noninvasive way by
programming the pacemaker to increasing frequen-
cies[1,9-11]. This test is especially useful in patients with
permanent pacemaker because of the fact that the nonin-
vasive diagnosis of CAD in this patients is an extremely
difficult task, since the induced rhythm by right ventricu-
lar pacing makes the electrocardiogram uninterpretable
and stress scintigraphy is plagued by an exorbitant
number of false positive results[1,14].
For the patients with Biventricular pacemakers, in cases
when limited maximal programmed rate is present, the
test should be done with right ventricular pacing mode, to
avoid the submaximal heart rate during the test leading to
decreased sensitivity, and increased number of the false
negative results respectively.
Protocol of pacing stress echocardiography: standard (left) or accelerated (right) Figure 4
Protocol of pacing stress echocardiography: standard (left) or accelerated (right).Cardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
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Pacing protocol
With external programming of the pacemaker, pacing is
started at 110 bpm and increased every 2 min by 10 bpm
until 85% target heart rate (220-years of age for men; 200-
years of age for women) is achieved (fig. 4) or until other
standard endpoints (chest pain, Echocardiographic posi-
tivity of ischemia, excessive blood pressure fall, limiting
dispnea) are reached. The same protocol can also be fol-
lowed in an accelerated fashion, with faster steps (20 to 30
seconds each) up to the target heart rate. The examination
is performed with the patient supine or in left lateral decu-
bitus. Two-dimensional echocardiographic images are
obtained before pacing and throughout the stress test, the
last recording being obtained after 3 min pacing at the
highest rate reached (usually 150 bpm) or target heart
rate. Blood pressure and the electrocardiogram are moni-
tored throughout the examination. Left ventricular wall
motion abnormalities are evaluated at rest, during pacing,
and immediately after pacing interruption[1].
Diagnostic results
Good diagnostic results have been obtained with invasive
atrial, or external (atrial or ventricular) pacing stress
echo[11,16]. All stress Echocardiographic diagnosis can
be easily summarized into equations, centred on regional
wall function, describing the fundamental response pat-
terns: normal, ischemic, viable, and necrotic (table 1).
In the Normal response, a segment is normokinetic at rest,
and normal-hyperkinetic during stress; in the Ischemic
response, a segment worsens its function during stress; in
the Necrotic response, a segment with resting dysfunction
remains fixed during stress; in the presence of Viability, a
segment with resting dysfunction improves during stress.
A resting akinesia which becomes dyskinesia during stress
reflects a purely passive, mechanical phenomenon of
increased intraventricular pressure, and should not be
considered as a true active ischemia[10].
As with other stress echo tests the positivity can be effec-
tively titrated in the time and space domain: more severe
degrees of underlying coronary artery disease are associ-
ated with a lower heart rate necessary to induce ischemia
and with more extensive wall motion abnormality
[17](fig. 5).
A test is considered positive if wall motion abnormalities
develop with stress in previously normal territories or
worsen in an already abnormal segment[18], (Additional
file1 and 2 – Pacing stress negative, Additional file3 and 4
– Pacing stress positive). Another marker of ischemia is
reduced regional systolic wall thickening [19].
According to the values derived from the PASE study[11],
the use of Noninvasive Pacemaker Stress Echocardiogra-
phy is diagnostically efficient option for patients with per-
manent PM and suspected or known CAD (Sensitivity
70%, Specificity 90% and Accuracy 78%).
The  Diagnostic Accuracy for all stress tests vary widely
because there are many factors affecting the test sensitiv-
ity. Among the factors that decreases the sensibility are:
Absence of previous myocardial infarct[1]; Presence of
antiischemic therapy[20]; Stenosis 50–75%, Single-vessel
disease, Simple stenosis morphology, Stenosis location
LCx, Submaximal stress intensity[1]; Echo interpreter with
a low level of competence [18,21,22].
Extend and severity of coronary artery disease (expressed by  the prognostically validated Duke score) is predicted by peak  Wall Motion Score Index (WMSI) during pacing stress  echocardiography Figure 5
Extend and severity of coronary artery disease (expressed by 
the prognostically validated Duke score) is predicted by peak 
Wall Motion Score Index (WMSI) during pacing stress 
echocardiography.
Table 1: Stress Echocardiography in Four Equations
Rest + Stress = Diagnosis
Normokinesis + Normo-Hyperkinesis = Normal
Normokinesis + Hypo,A,Dyskinesis = Ischemia
Akinesis + Hypo,Normokinesis = Viable
A-,Dyskinesis + A-,Dyskinesis = NecrosisCardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
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Limitations
The main limitation of the test is the suboptimal sensitiv-
ity in patients with single, and/or mild coronary artery dis-
ease, in which wall motion abnormalities may not
develop. At a high rate there are fewer video frames during
the ejection period and less time to appreciate a regional
wall motion abnormality. Only one third of patients can
be stressed in atrial stimulation mode that preserves the
physiological sequence of contraction of the left ventricle.
The external programming of the permanent pacemaker is
simple and fast, but it requires technology (external pro-
grammer) and expertise, with the need of minimum coop-
eration and coordination with the pacemaker
laboratory[1]. The main source of false negative result is
the inability to reach the target heart rate.
Advantages
Noninvasive pacemaker stress echocardiography has sev-
eral advantages in comparison to conventional diagnostic
techniques[23-25]. The relative merits and limitations of
noninvasive pacemaker stress echo versus pharmacologi-
cal stress echo are reported in Table 2[26-28]. The ability
to instantly lower rate and terminate stress result in high
test safety[4,29]. Differently from physical stress, it does
Time sequence during stress Figure 6
Time sequence during stress. The FFR can be defined as: upsloping when the peak stress pacing SP/ESV index is higher than 
baseline and intermediate stress values; biphasic with an initial upsloping followed by a later downsloping trend; and flat or nega-
tive when peak stress pacing systolic pressure/end-systolic volume index is equal or lower than baseline stress values.
Table 2: Pacing versus pharmacological stress echocardiography.
PACEMAKER PHARMACOLOGICAL
Modes Noninvasive PM (transesophageal) Vasodilation (dob)
Patient tolerability Very high High
Stress imaging time 5 to 10' 10 to 20'
Safety Very high High
Intravenous line Usually not required Required
Echo interpretation More difficult in ventricular paced Easier
Clinical experience Initial Extensive
Applicability Pts with permanent pacemaker All patientsCardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
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not require the patient's capability to exercise; differently
from pharmacological stress, it does not require an intra-
venous line and the additional cost (and risk) of drug
administration. It also has a shorter imaging time, because
the median time of pacing is less than 10 minutes with the
accelerated protocol, which compares favourably with the
about 15 minutes of infusion time for dipyridamole-atro-
pine and about 25 minutes of dobutamine-atropine. The
short duration of pacemaker stress echocardiography and
the possibility to perform the test at bedside make it very
well tolerated by the patient and user-friendly for the phy-
sician[1].
Pacing stress for contractility assessment through force-
frequency relationship
Estimating contractility of the left ventricle with non-inva-
sive techniques is an important yet elusive goal[9,12]. The
use of pacing stress echo to assess left ventricular contrac-
tile reserve is less established, but promising. Positive ino-
tropic interventions are mirrored by smaller end-systolic
volumes and higher end-systolic pressures. An increased
heart rate progressively increases the force of ventricular
contraction (Bowditch treppe or staircase phenome-
non)[9,12,30-33]. To build the force-frequency relation-
ship (FFR), the force is determined at different heart rate
steps as the ratio of the systolic pressure (SP), cuff sphyg-
momanometer/end-systolic volume index (ESV), biplane
Simpson rule/body surface area). The heart rate is deter-
minate from ECG. The FFR is built off line. The slope of
the relationship is calculated as the ratio between Systolic
Pressure/End-Systolic Volume (SP/ESV) index increase
(from baseline to peak pacing stress)/heart rate increase
(from baseline to peak pacing stress). The FFR can be
defined as: upsloping  (normal contractile reserve) when
the peak stress pacing SP/ESV index is higher than base-
line and intermediate stress values; biphasic (patients with
positive stress echo or latent left ventricular dysfunction)
with an initial upsloping followed by a later downsloping
trend; and flat or negative (Ischemic or Dilated Cardiomio-
pathy) when peak stress pacing systolic pressure/end-
systolic volume index is equal or lower than baseline
stress values[9,12,34] (fig: 6,7,8,9). This approach is cer-
tainly highly feasible and allows a conceptually immacu-
late definition of contractility[9,12,35]; recent studies are
reporting its prognostic usefulness[35,36] with a high pre-
dictive value of a flat-biphasic FFR for death or acute heart
failure; but its therapeutic implications remain to be
established.
The critical heart rate (or optimum stimulation fre-
quency) is defined as the heart rate at which systolic pres-
sure/ end-systolic volume index reached the maximum
Time sequence during stress Figure 7
Time sequence during stress. The FFR can be defined as: upsloping when the peak stress pacing SP/ESV index is higher than 
baseline and intermediate stress values; biphasic with an initial upsloping followed by a later downsloping trend; and flat or nega-
tive when peak stress pacing systolic pressure/end-systolic volume index is equal or lower than baseline stress values.
SP/ESVI
upsloping
biphasic
flat
Critical heart rate HRCardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
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value during progressive increase in heart rate; in biphasic
pattern, the critical heart rate is the heart rate beyond
which systolic pressure/end systolic volume index
declined by 5%; in negative pattern the critical heart rate
is the starting heart rate. Abnormal responses are identi-
fied on basis of the lower absolute value of FFR slope and
of the lower critical heart rate in the presence of abnormal
biphasic response of FFR over increasing frequencies. The
contraction frequency at which the FFR begins its
descending limb ("critical heart rate" or "optimum stimu-
lation frequency") declines progressively with the severity
of myocardial disease. Heart rate reduction increases con-
tractile force in end-stage failing human myocardium due
to an inverse force-frequency relation. Bowditch treppe,
assessed with pacing stress, can be used to assess the opti-
mal stimulation mode (AAI vs DDD vs VVI vs BIV) [37],
and the optimal stimulation frequency, and to optimise
the patient's chronotropic response in programming rate-
adaptive pacemakers[9,12]. More studies are needed to
compare the exercise capacity and the clinical outcome in
patients programmed to their optimal stimulation rate
versus patients who are programmed at more conven-
tional levels.
Perspectives
As the large and expanding population of patients with
permanent PM is present in today's cardiology practice
($2 billion PM in sales, implantation volume ranging
from 650 per million in high volume countries, such as
Belgium and France, to 200–400 per million in low vol-
ume countries such as United Kingdom)[9], the implica-
tion of this test is expected to be significantly increased in
the future. Beside already proved usefulness in the detec-
tion of coronary artery disease[1,11], recent studies sug-
gests extension of the test's utilisation in some other
clinical environments and settings: Clinical evaluation of
women with suspected CAD[38]; Post transplanta-
tion[38]; Assessment of Disease Severity, Risk Stratifica-
tion, and Prognosis in both Acute Ischemic Syndromes
and in Chronic CAD[38]; Before and after revascularisa-
tion[38,39], and in Predischarge evaluation [38]; As an
alternative diagnostic test for chest pain in elderly[40];
Evaluation of the drug interventions[41]; Pre-operative
evaluation in non-cardiologic patients[42]; Patients with
new-onset chest pain[43]; In Paediatric patients[44].
Conclusion
Two-dimensional echocardiography during pacing is a
useful tool in the detection of coronary artery disease.
Because of its safety and ease of repeatability noninvasive
Methodology of the force-frequency curve with pacemaker stress echo in normal subject Figure 8
Methodology of the force-frequency curve with pacemaker stress echo in normal subject. On the left, from upper to lower 
rows: heart rate from external programming of permanent pacemaker (first row); systolic blood pressure by cuff sphyg-
momanometar (second row); left ventricular end-systolic apical four (4C) and the two (2C) chamber view (third and fourth 
row); end-systolic volume calculated with biplane Simpson method (fifth row). An increased heart rate is accompanied by an 
increased systolic pressure with smaller end-systolic volumes (normal up sloping FFR).
HR               Baseline       +10     +20            +30              +40bpm
4C
Normal
2C
140 135 135 130 120 SP(mmHg)
  ESV (ml)            78 ml         68 ml            66 ml           61 ml            54 ml Cardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
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pacing stress echo can be the first-line stress test in
patients with permanent pacemakers. The use of pacing
stress echo to assess left ventricular contractile reserve is
less established, but promising. The force-frequency can
be defined as up-sloping (normal) when the peak stress
pacing systolic pressure/end-systolic volume index is
higher than baseline and intermediate stress values, bipha-
sic with an initial up- sloping followed by a later down-
sloping trend, or flat or negative when peak stress pacing
systolic pressure/end-systolic volume index is equal or
lower than baseline stress values. This approach is cer-
tainly highly feasible and allows a conceptually immacu-
late definition of contractility with prognostic usefulness,
but its therapeutic implications remains to be established.
Bowditch treppe, assessed with pacing stress, can be used
to assess the optimal stimulation frequency and to opti-
mise the patient's chronotropic response in programming
rate-adaptive pacemakers. More studies are needed to
compare the exercise capacity and the clinical outcome in
patients programmed to their optimal stimulation rate
versus patients who are programmed at more conven-
tional levels.
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Additional material
Additional File 1
Pacing stress negative, base.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-3-36-S1.mov]
Additional File 2
Pacing stress negative, peak.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-3-36-S2.mov]
Additional File 3
Pacing stress positive, base.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-3-36-S3.mov]
Methodology of the force-frequency curve with pacemaker stress echo in subject with post MI dilated cardiomyopathy and  depressed baseline left ventricular function (EF = 30%) Figure 9
Methodology of the force-frequency curve with pacemaker stress echo in subject with post MI dilated cardiomyopathy and 
depressed baseline left ventricular function (EF = 30%). On the left, from upper to lower rows: heart rate from external pro-
gramming of permanent pacemaker (first row); systolic blood pressure by cuff sphygmomanometar (second row); left ventricu-
lar end-systolic apical four (4C) and the two (2C) chamber view (third and fourth row); end-systolic volume calculated with 
biplane Simpson method (fifth row). An increased heart rate at peak pacing stress is accompanied by no change in end-systolic 
volumes (abnormal flat-biphasic FFR).
HR              Baseline           +10       +20           +30                +40bpm
SP(mmHg)
4C
DCM
2C
105 115 105 95 95
ESV (ml)          128 ml           114 ml         112 ml          114 ml           126 mlCardiovascular Ultrasound 2005, 3:36 http://www.cardiovascularultrasound.com/content/3/1/36
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